TY - JOUR AU - Bai, Yi AU - Zhao, Haitao PY - 2018 TI - A novel indication to treat distinct types of tumors with PD-1 blockade based on mismatch-repair deficiency JF - Annals of Research Hospitals; Vol 2 (February 2018): Annals of Research Hospitals Y2 - 2018 KW - N2 - Le et al . conducted a prospective study (Clinical-Trials.gov number, NCT01876511) to evaluate effects of programmed death-1 (PD-1) blockade (pembrolizumab) therapy in different kinds of tumors with mismatch repair-deficient (1). UR - https://arh.amegroups.org/article/view/3990